Related Experiment Video
Updated: Dec 15, 2025

Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
COVID-19: FAQs-Congenital Heart Surgery Recovery and Defining a "New Normal"
Joseph A Dearani1, Elizabeth H Stephens1, Kristine J Guleserian2
1Department of Cardiovascular Surgery, 4352Mayo Clinic, Rochester, MN, USA.
Abstract:
As recovery of congenital heart surgery programs begins during this COVID-19 pandemic, we review key considerations such as screening, protection of patients and health care workers (HCWs), case prioritization, barriers to reactivation, redesign of patient care teams, contribution of telemedicine, modification of trainees' experiences, preparation for potential resurgence, and strategies to maintain HCW wellness. COVID-19 has tested the resolve and grit of our specialty and we have an opportunity to emerge more refined.
Related Concept Videos
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Endocarditis III: Medical Management
Mitral Stenosis IV: Nursing Management
Coronary Artery Disease V: Interprofessional Care

